INmune Bio, Inc. (INMB)

INmune Bio Analyst Ratings

• Total Analysts: n/a
• Consensus Rating: n/a
• Price Target: n/a
• Upside: n/a

Ratings History

Filter results

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Joel Beatty Baird	Baird	Buy Initiates $16	Buy	Initiates	$16	+100.25%	Jun 1, 2023
Thomas Shrader BTIG	BTIG	Strong Buy Maintains $31 → $14	Strong Buy	Maintains	$31 → $14	+75.22%	May 24, 2022
Mayank Mamtani B. Riley Securities	B. Riley Securities	Strong Buy → Hold Downgrades $14 → $7	Strong Buy → Hold	Downgrades	$14 → $7	-12.39%	May 24, 2022
Mayank Mamtani B. Riley Securities	B. Riley Securities	Strong Buy Maintains $32 → $20	Strong Buy	Maintains	$32 → $20	+150.31%	Jan 24, 2022
Thomas Shrader BTIG	BTIG	Strong Buy Initiates n/a	Strong Buy	Initiates	n/a	n/a	Sep 1, 2020
Swayampakula Ramakanth HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains n/a	Strong Buy	Maintains	n/a	n/a	Jul 15, 2020
Swayampakula Ramakanth HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates n/a	Strong Buy	Reiterates	n/a	n/a	May 15, 2020
Jonathan Aschoff Roth Capital	Roth Capital	Strong Buy Initiates n/a	Strong Buy	Initiates	n/a	n/a	Dec 19, 2019